Development of New Heart Failure Treatment in Consideration of Cardiorenal Syndrome
Hiroshi Asanuma(Meiji University of Integrative Medicine), Masafumi Kitakaze(Hanwa Memorial Hospital), Seiji Takashima(The University of Osaka), Madoka Ihara(National Cerebral and Cardiovascular Center), H. Sasaki(Tohoku University), Masaru Sugimachi(National Cerebral and Cardiovascular Center), Miki Imazu(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University), Tetsuo Minamino(Kagawa University), Masanori Asakura(National Cerebral and Cardiovascular Center)
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288